Sherif Gerges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sherif Gerges has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Mark J. Daly
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, USA
2 shared publications - Sabina Berretta
Basic Neuroscience Division, McLean Hospital, Belmont, MA; Harvard Medical School, Boston, MA; Stanley Center for Psychiatric Research at Broad Institute
2 shared publications - Steven A. McCarroll
Harvard Medical School; Broad Institute; HHMI
2 shared publications - Alexander Ploss
Department of Molecular Biology, Princeton University
1 shared publication Angela S. Frankel
Division of Gastroenterology and Hepatology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
1 shared publication- Benjamin E. Low
The Jackson Laboratory, Bar Harbor, ME, USA, 04609
1 shared publication
Latest Publications
- Open Access
Genetic and structural evidence links Ca 2+ dysregulation and ATP2B2 to neuropsychiatric illness
Neuropsychiatric disorders are highly heritable, but the molecular mechanisms linking risk variants to disease remain unclear 1 . Linking genetics to biological mechanisms requires integrating evidence across scales, from sequence variation to gene regulation to protein function. Here we integrate genetic, transcriptomic, and structural evidence to identify dysregulation of neuronal Ca 2+ dynamics as a contributing mechanism. We analyzed single-nucleus neuronal RNA-seq data together with genome-wide association study (GWAS) heritability in a new way to identify gene expression programs enriched for psychiatric risk; genes encoding Ca 2+ flux pathway genes were implicated by this analysis, a result that was then confirmed by concentrations of rare coding variants in these same genes in persons with psychiatric disorders. A critical gene in this biology, ATP2B2 , encodes a Ca 2+ -extruding ATPase pump 2 linked to neuropsychiatric disorders primarily through missense variants. To recognize specific molecular functions affected by these missense variants, we developed a 3D-neighborhood-based method that maps missense variants onto AlphaFold3-predicted protein structures and tests clustering of protein-altering variants in three-dimensional space. This approach revealed clustering of these missense changes in the Ca 2+ pore and ATP:Mg 2+ coordination site of ATP2B2. To validate the structural predictions arising from the genetic analysis, we determined the structure of human Ca 2+ -bound ATP2B2 at 2.64 Å resolution by cryogenic electron microscopy. The structure replicated the 3D mutational hotspots identified by the genetic analysis, supporting the observation that neuropsychiatric variants cluster near specific catalytic sites of ATP2B2. In vitro experiments revealed that missense variants prioritized by the structural clustering analysis impaired ATP2B2-mediated Ca 2+ extrusion in cellular and biochemical assays. Together, these findings suggest that precise regulation of Ca 2+ dynamics is a contributing mechanism in neuropsychiatric disorders and establish a structure-based framework for predicting the mechanistic impact of missense variants.
Open AccessGenetic and structural evidence links Ca 2+ dysregulation and ATP2B2 to neuropsychiatric illness
Neuropsychiatric disorders are highly heritable, but the molecular mechanisms linking risk variants to disease remain unclear 1 . Linking genetics to biological mechanisms requires integrating evidence across scales, from sequence variation to gene regulation to protein function. Here we integrate genetic, transcriptomic, and structural evidence to identify dysregulation of neuronal Ca 2+ dynamics as a contributing mechanism. We analyzed single-nucleus neuronal RNA-seq data together with genome-wide association study (GWAS) heritability in a new way to identify gene expression programs enriched for psychiatric risk; genes encoding Ca 2+ flux pathway genes were implicated by this analysis, a result that was then confirmed by concentrations of rare coding variants in these same genes in persons with psychiatric disorders. A critical gene in this biology, ATP2B2 , encodes a Ca 2+ -extruding ATPase pump 2 linked to neuropsychiatric disorders primarily through missense variants. To recognize specific molecular functions affected by these missense variants, we developed a 3D-neighborhood-based method that maps missense variants onto AlphaFold3-predicted protein structures and tests clustering of protein-altering variants in three-dimensional space. This approach revealed clustering of these missense changes in the Ca 2+ pore and ATP:Mg 2+ coordination site of ATP2B2. To validate the structural predictions arising from the genetic analysis, we determined the structure of human Ca 2+ -bound ATP2B2 at 2.64 Å resolution by cryogenic electron microscopy. The structure replicated the 3D mutational hotspots identified by the genetic analysis, supporting the observation that neuropsychiatric variants cluster near specific catalytic sites of ATP2B2. In vitro experiments revealed that missense variants prioritized by the structural clustering analysis impaired ATP2B2-mediated Ca 2+ extrusion in cellular and biochemical assays. Together, these findings suggest that precise regulation of Ca 2+ dynamics is a contributing mechanism in neuropsychiatric disorders and establish a structure-based framework for predicting the mechanistic impact of missense variants.
- 27 September 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 51, e83-e84
80. SINGLE-CELL RNA-SEQUENCING OF HUMAN BRAIN REGIONS IDENTIFIES CELL TYPES AND STATES RELEVANT TO DISEASE
- 27 September 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 51, e83-e84
80. SINGLE-CELL RNA-SEQUENCING OF HUMAN BRAIN REGIONS IDENTIFIES CELL TYPES AND STATES RELEVANT TO DISEASE
- 27 June 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (447)
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection
An inbred mouse model for HDV infection can be used to study virally induced immune responses and for testing antiviral therapeutics.
- 27 June 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (447)
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection
An inbred mouse model for HDV infection can be used to study virally induced immune responses and for testing antiviral therapeutics.